Plunkett Research Online: RespireRx Pharmaceuticals Inc

RESPIRERX PHARMACEUTICALS INC (RSPI:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

RespireRx Pharmaceuticals Inc is engaged in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is developed for the treatment of OSA (Obstructive Sleep Apnea), a f.....



RespireRx Pharmaceuticals Inc
Ticker: RSPI
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 201-444-4947
Fax:
Address: 126 Valley Road
Suite C
Glen Rock, NJ 07452 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Neurological
Drug Development
Pharmaceutical Cannabinoids
Neuromodulators
Contacts Description
Maria MessingerCFO/Chief Accounting Officer/Secretary/Vice President
Roger StollChairman of the Board/Director
See More
RespireRx Pharmaceuticals Inc is engaged in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The pipeline products of the company are dronabinol which is developed for the treatment of OSA (Obstructive Sleep Apnea), a f.....See More See More

Auditor: Haskell & White LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
ResolutionRx
EndeavourRx
AMPAkines
GABAkines
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: